Coya Therapeutics: Dr. Adrian Hepner resigns as President/CMO, replaced by Dr. Fred Grossman

Coya Therapeutics, Inc.

Dr. Fred Grossman appointed President and CMO effective July 17, 2023, succeeding Dr. Adrian Hepner who resigned.
Base salary $450,000/year; annual bonus target 40% of base salary based on company-set objectives.
Two option grants each for 74,069 shares (first on start date, second Jan 2024); 24,689 shares vest after 1 year, remainder over 24 months.
Employment agreement initial term of 2 years, auto-renews annually unless either party gives 30-day notice.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Fred Grossman

President and Chief Medical Officer

COYA · Coya Therapeutics, Inc.

Effective: 2023-07-17
Filed: July 10, 2023, 7:59 PM ET

On July 3, 2023, the Company appointed Dr. Fred Grossman President and Chief Medical Officer, effective July 17, 2023.

Departed

Dr. Adrian Hepner

President and Chief Medical Officer

COYA · Coya Therapeutics, Inc.

Effective: 2023-07-17
Successor: Dr. Fred Grossman
Filed: July 10, 2023, 7:59 PM ET

Dr. Adrian Hepner, the current President and Chief Medical Officer of Coya Therapeutics, Inc. (the “Company”), has informed the Company that he will resign from his position effective July 17, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Fred Grossman was appointed as President and Chief Medical Officer at Coya Therapeutics, Inc..

Action: appointed
Role: President and Chief Medical Officer

Exact text from the filing

On July 3, 2023, the Company appointed Dr. Fred Grossman President and Chief Medical Officer, effective July 17, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Adrian Hepner resigned as President and Chief Medical Officer at Coya Therapeutics, Inc..

Action: resigned
Role: President and Chief Medical Officer

Exact text from the filing

Dr. Adrian Hepner, the current President and Chief Medical Officer of Coya Therapeutics, Inc. (the “Company”), has informed the Company that he will resign from his position effective July 17, 2023.

View on SEC.gov

Coya Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-184752

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.